Dry powder drug delivery system
US10342938B2 · kind B2 · utility
0Cited by
907References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 14, 2016 |
| Grant date | Jul 9, 2019 |
| Priority date | — |
| Expiry date | Jun 14, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61M2205/6081
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A pulmonary drug delivery system is disclosed, including a breath-powered, dry powder inhaler, and a cartridge for delivering a dry powder formulation. The inhaler and cartridge can be provided with a drug delivery formulation comprising, for example, a diketopiperazine and an active ingredient, including, peptides and proteins such as insulin and glucagon-like peptide 1 for the treatment of endocrine disease, for example, diabetes and/or obesity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.